|
Market Closed -
Xetra
19:35:45 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 52.45 EUR | +3.92% |
|
+3.92% | - |
| 08-13 | Zealand Pharma sells rusfertide rights for $100m | FW |
| 08-13 | Zealand Pharma to Sell Rusfertide-linked Economics to Royalty Pharma for $100 Million | MT |
Chart: Technical Analysis
Stock exchange
Xetra
RPD 52.45 €
+3.92%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| RPRX | 61.31USD | +1.21% | 143M $ | |
CBOE
| RPRX | 61.36USD | +1.34% | 4.9M $ | |
|
Mexican S.E.
| RPRX N | 1,005.77MXN | -1.92% | 5.03M $ | |
|
Börse Stuttgart
| RPD | 52.42EUR | +1.14% | 2.1K € | |
|
Boerse Muenchen
| RPD | 52.49EUR | +1.23% | 1.26K € | |
|
Deutsche Boerse AG
| RPD | 50.57EUR | -2.15% | 0 € | |
|
Tradegate
| RPD | 52.49EUR | +1.21% | 0 € | |
|
Xetra
| RPD | 52.45EUR | +3.92% | 0 € |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RPRX Stock
- RPD Stock
- Charts Royalty Pharma plc
Select your edition
All financial news and data tailored to specific country editions
